Leukemia & Lymphoma
Volume 63, 2022 - Issue 1
Open access
3,622
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor
Prognostication of diffuse large B-cell lymphoma patients with Deauville score of 3 or 4 at end-of-treatment PET evaluation: a comparison of the Deauville 5-point scale and the ΔSUVmax method
David Z. Nga Internal Medicine Residency, SingHealth Services, SingaporeView further author information
, Chuan Yaw Leea Internal Medicine Residency, SingHealth Services, SingaporeView further author information
, Winnie W. Lamb Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore;c Duke-NUS Medical School, Radiological Sciences Academic Clinical Programme, Singapore
https://orcid.org/0000-0002-9813-9857View further author information
Aaron K. Tongb Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore;c Duke-NUS Medical School, Radiological Sciences Academic Clinical Programme, SingaporeView further author information
, Sze Huey Tand Biostatistics Unit, National Cancer Centre Singapore, SingaporeView further author information
, Lay Poh Khooe Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
, Ya Hwee Tane Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
, Jianbang Chiange Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
, Esther W. Change Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
, Jason Y. Chane Division of Medical Oncology, National Cancer Centre Singapore, Singapore;f Duke-NUS Medical School, Oncology Academic Clinical Programme, SingaporeView further author information
, Eileen Y. Poone Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
, Nagavalli Somasundarame Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
, Mohamed Farid H. Rashide Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
, Miriam Taoe Division of Medical Oncology, National Cancer Centre Singapore, SingaporeView further author information
, Soon Thye Lime Division of Medical Oncology, National Cancer Centre Singapore, Singapore;f Duke-NUS Medical School, Oncology Academic Clinical Programme, SingaporeView further author information
& Valerie S. Yange Division of Medical Oncology, National Cancer Centre Singapore, Singapore;f Duke-NUS Medical School, Oncology Academic Clinical Programme, Singapore;g Translational Precision Oncology Laboratory, Institute of Molecular & Cell Biology, A*STAR, SingaporeCorrespondence[email protected]
https://orcid.org/0000-0002-8844-9421View further author information
Pages 256-259
|
Received 13 Jun 2021, Accepted 28 Sep 2021, Published online: 19 Oct 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.